AMENDMENT No. 1Consulting Agreement • November 6th, 2019 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 01 (“Amendment”) is entered into as of September 16, 2019 (the “Amendment Effective Date”) between Dinah Sah (“Consultant”) and Voyager Therapeutics, Inc. (“Voyager”) and relates to the Agreement referred to below.
AMENDMENT No. 1Consulting Agreement • November 6th, 2019 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 01 (“Amendment”) is entered into as of July 9, 2019 (the “Amendment Effective Date”) between Steven M. Paul, M.D. (“Company”) and Voyager Therapeutics, Inc. (“Voyager”) and relates to the Agreement referred to below.
